SecBot SecBot
8-K ·Filed Mar 23, 2026

ABT

ABBOTT LABORATORIES
BULLISH
Impact 8/10
Horizonmonths Processed7mo ago SEC0001104659-26-033079
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

The acquisition significantly strengthens Abbott's position in high-growth cancer diagnostics. Traders should monitor integration progress and synergy realization. The deal may lead to upward revisions in Abbott's long-term growth guidance.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$104.84
T+0 close · Mar 23, 2026 · via day close
Latest settled
−13.56%
T+60 · $90.62
Vs SPY
−28.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 23 $104.84entry
  2. T+1 · 8mo ago −0.76%α −0.41% · $104.04
  3. T+5 · 8mo ago −2.84%α +0.72% · $101.86
  4. T+20 · 7mo ago −11.55%α −18.97% · $92.73
  5. T+60 · 5mo ago −13.56%α −28.05% · $90.62
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Abbott Laboratories completed the acquisition of Exact Sciences for $105.00 per share in cash, establishing Abbott as a leader in cancer screening and diagnostics. The deal adds Exact Sciences' portfolio, including Cologuard and Oncotype DX, to Abbott's diagnostics business.

Key Facts

  • Abbott completed the acquisition of Exact Sciences on March 23, 2026
  • Exact Sciences shareholders received $105.00 per share in cash
  • Exact Sciences is now a wholly owned subsidiary of Abbott
  • The deal establishes Abbott as a leader in the $60 billion U.S. cancer screening and precision oncology diagnostics market
  • Key products acquired include Cologuard, Oncotype DX, Oncodetect, and Cancerguard

Financial Impact

Total deal value approximately $13.7 billion based on Exact Sciences' ~130 million shares outstanding at $105/share

cashdebtrevenuestrategic positioning

Risk Factors

  • Integration challenges between the two organizations
  • Failure to realize anticipated synergies
  • Regulatory or operational hurdles in combining the businesses
  • Potential dilution of Abbott's earnings in the near term

Market Snapshot

Price
$105.15
Volume
100
Exchange
NYSE
Analyst Consensus
71% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-033079
Document: tm268709d2_ex99-1.htm0001104659-26-033079
Document: 0001104659-26-033079-index-headers.html0001104659-26-033079
Document: 0001104659-26-033079-index.html0001104659-26-033079
Document: 0001104659-26-033079.txt0001104659-26-033079

Track record

38 reports on ABT

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +17.16% at T+20 after the Jul 1, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 5, 202611d ago 144 Neutral 2/10 Entry $109.93 Now $108.52 −1.28% settles Dec 7
  2. Oct 27, 202620d ago ANALYST-DOWNGRADE Neutral 2/10 Entry $103.10 Now $108.52 +5.26% settles Nov 24
  3. Oct 27, 202621d ago Court Ruling Neutral 1/10 Entry $102.64 Now $108.52 +5.73% settles Nov 25
  4. Oct 21, 202626d ago Institutional Cluster Mixed 4/10 Entry $102.51 Now $108.52 +5.86% settles Nov 19
  5. Oct 21, 202626d ago 8-K Bullish 6/10 Entry $100.51 Now $108.52 +7.97% settles Nov 18
  6. Oct 21, 202626d ago 8-K Bearish 6/10 No price data
  7. Oct 21, 202626d ago Press Release Neutral 4/10 Entry $100.51 Now $108.52 +7.97% settles Nov 18
  8. Oct 20, 202628d ago Court Ruling Neutral 1/10 Entry $100.51 Now $108.52 +7.97% settles Nov 18
  9. Oct 16, 20264w ago Court Ruling Neutral 2/10 Entry $104.06 to $107.45 Now $108.52 +4.29% ▲ +3.26% +6.72% vs SPY
  10. Oct 15, 20264w ago Court Ruling Bullish 5/10 Entry $104.89 to $108.52 Now $108.52 +3.46% ▲ +3.46% +4.62% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens Wed (12h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 23, 2026